How to Take Propolis: Form, Dosage and Duration

There is no universal dose, and that is the central point of this article. Propolis is not a molecule but a raw material whose composition varies according to botanical origin. A dose only makes sense when related to a content of active compounds. In the reference ENT study, the administered dose was 12 to 24 mg of polyphenols per day, in the form of a titrated oral spray.

Because this figure indicates a weight of material, not a quantity of active compounds. Two 500 mg propolis products can have very different polyphenol contents depending on the trees foraged, the region, and the season. It's the equivalent of announcing a juice volume without saying which fruit it comes from.

Two pieces of information. The botanical origin, poplar propolis or another type, because the compound profiles differ completely. And the polyphenol or flavonoid content, which is the only data allowing you to calculate an actual intake and compare two products with each other.

Nothing in the available literature supports this logic. The studies use defined doses over defined periods, and none has tested an increasing dose-effect relationship. Increasing a dose without experimental basis primarily increases exposure, and thus the sensitization risk mentioned above.

It's a matter of usage rather than efficacy. The capsule provides a fixed and reproducible dose, masks the taste, and is easily portable, which promotes consistency. Powder allows you to freely adjust the quantity and incorporate it into a drink or preparation, at the cost of a pronounced resinous taste that not everyone appreciates.

It's the form used in the trial concerning the upper respiratory tract, where direct contact with the throat mucosa is part of the principle. This doesn't make it superior in general: for a foundational intake by oral route, the question of local contact doesn't arise. The form should be chosen based on the intended use.

No, and we prefer to state this clearly. That trial involved a standardized oral spray, administered in three divided daily doses. We offer powder and capsules, which reproduce neither the route of administration nor the dosing schedule. We therefore do not transpose those results to our products.

It's the most traditional and least reproducible form. Raw propolis is neither purified nor standardized: its composition depends entirely on the batch, and there's no way to know what you're ingesting. For documented use, a form with known content remains preferable.

This randomized double-blind placebo-controlled trial included 122 adults with mild upper respiratory symptoms. After three days, 83% of participants in the propolis group had no symptoms, compared to 72% in the placebo group who retained at least one symptom. By day five, all participants in both groups had recovered. No adverse effects were reported.

It's interesting but its limitations should be understood. It's a single-center trial on 122 people, and it's an isolated study rather than a meta-analysis combining multiple trials. Additionally, one of the authors is affiliated with an industrial research unit. These are elements the reader should keep in mind to form their own opinion.

A randomized double-blind trial on 104 subjects tested a complex combining propolis and mangosteen over eight weeks. Local inflammatory markers decreased significantly, but clinical parameters did not differ significantly between groups. This is a classic gap between biology and clinical outcomes, and it deserves to be reported rather than concealed.

Primarily because the products tested are not the same. European poplar propolis and Brazilian green propolis have very different compound profiles. Add to this the differences in form, dose, and duration. Comparing two studies on "propolis" often amounts to comparing two distinct substances.

Yes, and this is the best documented point. In the baseline European series tested on 22,581 patients in 2019 and 2020, propolis is the newly added allergen most frequently positive, at 3.48%. A Central European network covering 125,436 patients notes a clearly increasing trend, with 3.94% over the 2015-2018 period.

No, and this is a frequent misreading. These figures concern patients referred to dermatology for suspected contact allergy, a population by definition selected. The prevalence in the general population is lower. What matters here is the increasing trend, which the authors deem worthy of investigation.

People allergic to hive products, honey, pollen, or hymenoptera stings. Those with known allergies to poplar resins or balsam of Peru, with which cross-reactions are described. And anyone who has previously reacted to a cosmetic containing it. In case of doubt, the question should be discussed with a healthcare professional.

The cited trials concern adults, so they allow no extrapolation to children. Add to this the fact that tinctures contain alcohol, which rules them out from the start. In children, the approach is to seek the advice of a doctor or pharmacist rather than transposing an adult dose.

Published protocols range from five days for occasional use to eight weeks for a foundational goal. None support indefinite use. The right approach is to set a duration before beginning and take a break, rather than let a regimen become open-ended.

No trial has compared these two times, so there is no data to settle the question. What the protocols show varies: for local use, doses are distributed throughout the day, typically three times. For foundational use, consistency matters, not the time of day.

That the weight listed on a propolis label tells you nothing, and that polyphenol content and botanical origin are the only two pieces of information that allow you to dose and compare. That the form tested in a trial is part of the result, an oral spray not being the same as a capsule. And that the risk of sensitization is increasing in Europe, which justifies excluding people allergic to hive products from the start.